04/23/2024
7:32 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2024
4:19 PM | Akebia Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2024
4:48 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:49 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:46 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:47 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/29/2024
5:00 PM | Akebia Therapeutics (Issuer)
Butler John P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:01 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:02 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:03 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:32 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:11 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:14 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:16 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:19 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:52 PM | Akebia Therapeutics (Subject)
Butler John P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
3:40 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:21 PM | Akebia Therapeutics (Issuer)
Grund Nicholas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/18/2024
3:21 PM | Akebia Therapeutics (Issuer)
Malabre Richard C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:02 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
4:07 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
6:33 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
3:34 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:31 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2023
3:47 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2023
7:55 AM | Akebia Therapeutics (Filer)
| Form 10-K/A | |
08/28/2023
7:57 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/25/2023
7:14 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
6:35 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:30 PM | Akebia Therapeutics (Issuer)
Snow Ellen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2023
6:47 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
6:04 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
3:30 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
6:31 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:01 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
7:00 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
6:34 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Wall Street Legend Issues New NVDA Warning (Ad) Legendary Stockpicker: "Buy this A.I. stock NOW"
His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock. Click here for the stock details |
05/25/2023
8:01 PM | Akebia Therapeutics (Issuer)
Dahan Michel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
8:01 PM | Akebia Therapeutics (Issuer)
Hadas Nicole R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/25/2023
4:01 PM | Akebia Therapeutics (Subject)
Hadas Nicole R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023
3:44 PM | Akebia Therapeutics (Subject)
Dahan Michel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023
7:05 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
6:59 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
5:19 PM | Akebia Therapeutics (Issuer)
Spellman David A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
5:20 PM | Akebia Therapeutics (Issuer)
Burke Steven Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2023
4:32 PM | Akebia Therapeutics (Subject)
Burke Steven Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023
6:50 AM | Akebia Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2023
6:40 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2023
6:41 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
9:41 AM | Akebia Therapeutics (Filer)
| Form ARS | |
04/28/2023
6:30 AM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2023
4:10 PM | Akebia Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
